Home > Insider Trading > Filing (0001144204-18-066041)

Filing Details

Accession Number:: 0001144204-18-066041
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-21 16:16:38
Reporting Period:: 2018-12-19

Accepted Time:: 2018-12-21 16:16:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1484565	Soleno Therapeutics Inc	SLNO	()	NY

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
926475	N Larry Feinberg	262 Harbor Drive, 3Rd Floor Stamford CT 06902		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share ("Common Stock")	Acquisiton	2018-12-19	849,805	$1.61	2,519,346	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2018-12-19	283,268	$1.61	834,691	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2018-12-19	112,062	$1.61	329,158	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant (Right to Buy)	Acquisiton	2018-12-19	42,490	$0.00	42,490	$2.00
Common Stock	Common Stock Warrant (Right to Buy)	Acquisiton	2018-12-19	14,163	$0.00	14,163	$2.00
Common Stock	Common Stock Warrant (Right to Buy)	Acquisiton	2018-12-19	5,603	$0.00	5,603	$2.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
42,490	2019-06-19	2023-12-19	No	4	P	Indirect
14,163	2019-06-19	2023-12-19	No	4	P	Indirect
5,603	2019-06-19	2023-12-19	No	4	P	Indirect

Footnotes

These securities are owned by Oracle Partners, LP. ("Partners").
These securities are owned by Oracle Ten Fund, L.P. ("Ten Fund").
These securities are owned by Oracle Institutional Partners, L.P. ("Institutional Partners")
Larry N. Feinberg serves as the managing member of Oracle Associates, LLC, the general partner of Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the indirect beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund. Mr. Feinberg is the sole shareholder, director and president of Oracle Investment Management, Inc., which serves as investment manager to Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund.
Each of the Reporting Persons identified in this statement disclaims beneficial ownership of the securities described in this statement, except to the extent of their individual respective pecuniary interest in such securities. The filing of this statement shall not be deemed an admission that any of the Reporting Persons identified in this statement are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any securities specified in this statement other than those directly beneficially owned by them.
The reported securities are included within 849,805 units purchased by Partners for $1.60625 per unit. Each unit consists of one share of common stock and one warrant to acquire 5% of a share of Common Stock.
The reported securities are included within 283,268 units purchased by Ten Fund for $1.60625 per unit. Each unit consists of one share of common stock and one warrant to acquire 5% of a share of Common Stock.
The reported securities are included within 112,062 units purchased by Institutional Partners for $1.60625 per unit. Each unit consists of one share of common stock and one warrant to acquire 5% of a share of Common Stock.